[Treatment of radiation-induced late effects: What's new?]

Abstract

Mechanisms of late radio-induced lesions are the result of multiple and complex phenomena, with many entangled cellular and tissue factors. The biological continuum between acute and late radio-induced effects will be described, with firstly a break in homeostasis that leads to cellular redistributions. New insights into late toxicity will finally be addressed. Individual radiosensitivity is a primary factor for the development of late toxicity, and clinicians urgently need predictive tests to offer truly personalized radiation therapy. An update will be made on the various functional and genetic tests currently being validated. The management of radio-induced side effects remains a frequent issue for radiation oncologists, and an update will be made for certain specific clinical situations. Finally, an innovative management for patients with significant side effects after pelvic radiotherapy will be developed, involved mesenchymal stem cell transplantation, with the presentation of the "PRISME" protocol currently open to patients recruitment.

Keywords: Cellules souches mésenchymateuses; Effets secondaires de la radiothérapie; Mesenchymal stem cells; Radiation-induced toxicity; Radiosensibilité; Radiosensitivity; Radiotherapy; Radiothérapie; Side effects of radiation therapy; Toxicité radio-induite.